术前对比增强乳腺X线摄影中肿瘤累及乳头:一项多中心诊断准确性研究
这项回顾性多中心研究纳入2016年12月至2023年12月五家转诊中心530例活检证实乳腺癌并接受初次手术的患者,评估术前对比增强乳腺X线摄影(CEM)判断乳头病理受累的诊断准确性。病理乳头受累见于147/558个癌(26.3%);CEM特异度95.1%,阳性预测值83.5%,阳性似然比14.1;伴乳头受累的CEM特征包括乳晕周围皮肤增厚、浅表线样强化中断、乳头回缩,最小强化至乳头距离每增加1 mm与受累风险降低相关,9.5 mm截断值预测最佳。
要点
- CEM判断乳头病理受累特异度95.1%(391/411),阳性预测值83.5%(101/121),阳性似然比14.1。
- 乳晕周围皮肤增厚(OR 3.8)、浅表线样强化中断(OR 3.0)、乳头回缩(OR 2.2)与乳头受累相关。
- 最小强化至乳头距离每增加1 mm,乳头受累风险降低(OR 0.94),9.5 mm截断值预测最佳。
核心结论
- 术前CEM有助于准确判断乳腺癌的乳头病理受累。
研究设计与样本
- 回顾性多中心诊断准确性研究,纳入530例女性(558个癌),来自五家转诊中心,2016年12月至2023年12月接受术前CEM并接受初次手术,以手术病理为参考标准,由≥5年经验的乳腺放射科医师进行本地图像复核。
关键影像表现/征象
- 与乳头病理受累相关的CEM特征包括乳晕周围皮肤增厚(OR 3.8;95% CI: 1.7, 8.4;P < .001)。
- 浅表线样强化中断与乳头病理受累相关(OR 3.0;95% CI: 1.3, 7.0;P = .01)。
- 乳头回缩与乳头病理受累相关(OR 2.2;95% CI: 1.1, 4.6;P = .03)。
- 最小强化至乳头距离每增加1 mm,与乳头病理受累风险降低相关(OR 0.94;95% CI: 0.93, 0.96;P < .001)。
诊断标准与关键数值
- CEM判断乳头病理受累的特异度为95.1%(391/411;95% CI: 92.6, 97.0)。
- CEM判断乳头病理受累的阳性预测值为83.5%(101/121;95% CI: 76.5, 88.7)。
- CEM判断乳头病理受累的阳性似然比为14.1(95% CI: 9.1, 22.0)。
- 最小强化至乳头距离以9.5 mm为截断值最佳预测乳头病理受累(Youden指数0.53)。
临床应用与阅片要点
- 术前CEM可用于帮助判断乳腺癌乳头病理受累,乳晕周围皮肤增厚、浅表线样强化中断和乳头回缩提示受累风险增高。
- 最小强化至乳头距离每增加1 mm与乳头受累风险降低相关,9.5 mm截断值对判断乳头受累具有参考价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Assessing nipple involvement in breast cancer at preoperative imaging is crucial for nipple-preserving surgery, but no studies have investigated the utility of contrast-enhanced mammography (CEM) in this assessment. Purpose To evaluate the diagnostic accuracy of CEM in ruling in pathologic nipple involvement and identify associated CEM features. Materials and Methods This retrospective multicenter study included patients with biopsy-proven breast cancer treated with primary surgery who underwent preoperative CEM at five referral centers between December 2016 and December 2023. After local image review by board-certified breast radiologists (with ≥5 years of experience), CEM diagnostic accuracy indexes to rule in nipple involvement (specificity [ie, primary end point], positive predictive value, and positive likelihood ratio) were calculated with surgical pathologic findings serving as the reference standard. Associations of CEM features with pathologic nipple involvement and the minimum enhancement-to-nipple distance to rule in pathologic nipple involvement were evaluated by using multivariable logistic regression analysis (adjusted odds ratios [ORs]) and the Youden index. Results Pathologic nipple involvement was present in 147 of 558 (26.3%) cancers from 530 included women (median age, 63.7 years; IQR, 50.4-73.6 years). CEM specificity was 95.1% (391 of 411; 95% CI: 92.6, 97.0), with a positive predictive value of 83.5% (101 of 121; 95% CI: 76.5, 88.7) and a positive likelihood ratio of 14.1 (95% CI: 9.1, 22.0). CEM features associated with pathologic nipple involvement were as follows: periareolar skin thickening (OR, 3.8; 95% CI: 1.7, 8.4; P < .001), disrupted superficial linear enhancement (OR, 3.0; 95% CI: 1.3, 7.0; P = .01), nipple retraction (OR, 2.2; 95% CI: 1.1, 4.6; P = .03), and (with lower odds) 1-mm increases in the minimum enhancement-to-nipple distance (OR, 0.94; 95% CI: 0.93, 0.96; P < .001). For the minimum enhancement-to-nipple distance, a 9.5-mm cutoff best predicted pathologic nipple involvement (Youden index, 0.53). Conclusion CEM was able to help accurately rule in pathologic nipple involvement in the preoperative setting. Supplemental material is available for this article. © RSNA, 2025.
引用
- Cozzi A, Bellini C, Girometti R, et al. Tumor Involvement of the Nipple at Preoperative Contrast-enhanced Mammography: A Multicenter Diagnostic Accuracy Study. Radiology. 2025. PMID: 41186466. doi:10.1148/radiol.251350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。